Pharmaceutical, clinical, and resistance information on doravirine, a novel non-nucleoside reverse transcriptase inhibitor for the treatment of HIV-1 infection

• Main Authors: Hanh Thi Pham (Author), Meng A Xiao (Author), Miguel AV Principe (Author), Alexander Wong (Author), Thibault Mesplède (Author)
• פורמט: ספר
• יצא לאור: BioExcel Publishing Ltd, 2020-03-01T00:00:00Z.
• נושאים: article
• גישה מקוונת: Connect to this object online.

As part of a combined antiretroviral regimen, doravirine is safe and effective at suppressing viral replication in both treatment-naive and treatment-experienced adults living with human immunodeficiency virus (HIV)-1 who have no history of drug resistance against doravirine. In virologically suppre...